Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 16 for:    Gantenerumab

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03443973
Recruitment Status : Active, not recruiting
First Posted : February 23, 2018
Last Update Posted : September 13, 2021
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 30, 2022
Estimated Study Completion Date : November 3, 2023